Abiopharma

🔍 Wallach Matthew J (Director)

Company: VEEVA SYSTEMS INC (VEEV)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Acquired 253 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 106,173.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: H | nature_of_ownership: By Matt Wallach 2012 Irrevocable Trust dated October 15, 2012 | shares_owned_after: 100,000.00 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: H | nature_of_ownership: By Matt Wallach 2013 Irrevocable Trust dated August 13, 2013 | shares_owned_after: 100,002.00 | Footnotes: F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: H | nature_of_ownership: By Matt Wallach 2012 Irrevocable Non-Grantor Trust dated October 15, 2012 | shares_owned_after: 50,000.00 | Footnotes: F4
• Sold 253 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 760.00 | transaction_form_type: 4 | Footnotes: F5, F1, F6, F6

Footnotes:

• F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
• F2: Shares held by Matt Wallach 2012 Irrevocable Trust dated October 15, 2012 ("Trust I"). The Reporting Person may be deemed to share voting and dispositive power with regard to the reported shares held by Trust I. The Reporting Person disclaims beneficial ownership of the reported shares held by Trust I, except to the extent, if any, of his pecuniary interest therein.
• F3: Shares held by Matt Wallach 2013 Irrevocable Trust dated August 13, 2013 ("Trust II"). The Reporting Person may be deemed to share voting and dispositive power with regard to the reported shares held by Trust II. The Reporting Person disclaims beneficial ownership of the reported shares held by Trust II, except to the extent, if any, of his pecuniary interest therein.
• F4: Shares held by Matt Wallach 2012 Irrevocable Non-Grantor Trust dated October 15, 2012 ("Trust III"). The Reporting Person may be deemed to share voting and dispositive power with regard to the reported shares held by Trust III. The Reporting Person disclaims beneficial ownership of the reported shares held by Trust III, except to the extent, if any, of his pecuniary interest therein.
• F5: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
• F6: On June 18, 2025, the Reporting Person was granted 1,013 RSUs under the Issuer's Amended & Restated 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 1, 2025, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.